ArticleArchives of medical science : AMS2026
The effect of regular physical activity during hemodialysis on levels of FOXO proteins and myostatin concentration.
Article in Archives of medical science : AMS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The implementation of virtual reality (VR) technology in the context of hemodialysis represents a groundbreaking approach that has the potential to greatly enhance patients' motivation to engage in physical exercise. Physical exercise during hemodialysis has a positive impact on chronic inflammation, well-being, muscle mass and strength, and the risk of cardiovascular diseases. The aim of this study was to comprehensively evaluate the impact of regular physical activity using VR during hemodialysis sessions on plasma concentrations of myostatin and FOXO proteins, with particular emphasis on enhancing training attractiveness and patient motivation. Material and methods: The study was conducted at the Department of Nephrology, Transplantology, and Internal Diseases in Szczecin (Poland). The study and the control groups consisted of end-stage renal disease patients who underwent hemodialysis as a renal replacement treatment. The study group was tasked with engaging in training sessions using the NefroVR system prototype. In contrast, patients in the control group did not participate in any intervention. To assess the concentrations of FOXO1, FOXO2, FOXO3 and myostatin parameters, blood was collected from the subjects twice: on the day of study initiation and after 3 months. Results: A total of 102 patients were selected for participation in the study. The study group showed lower FOXO-1 values compared to the control group at measurement 2 ( Conclusions: The study findings suggest that training performed 3 times a week for 3 months through VR could reduce FOXO-1 protein levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.